{"document": {"publication": "Tag My News", "full_text": "people with advanced melanoma who were treated with bristol-myers squibb co's yervoy plus chemotherapy lived an average of two months longer than people who got chemotherapy alone, in the first of many combination studies slated for this promising new drug.", "title": "melanoma drug extends life in second large study", "line_count": 1, "filename": "11591", "publication_date": "05-06-2011 15:50:29", "lines_and_colors": [["people with advanced melanoma who were treated with bristol-myers squibb co's yervoy plus chemotherapy lived an average of two months longer than people who got chemotherapy alone, in the first of many combination studies slated for this promising new drug.", {}]]}}